Anti-CD47 antibodies and methods of use

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9803016
SERIAL NO

15473206

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed herein are anti-CD47 antibody molecules, their manufacture and use in treating disorders associated with CD47 expression, for example, certain hematological cancers and solid tumors.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ERASMUS UNIVERSITY MEDICAL CENTERP O BOX 2040 DEPARTMENT OF CELL BIOLOGY AND GENETRICS ROTTERDAM NL-3000 CA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chappel, Scott Milton, US 18 36
Grosveld, Frank Rotterdam, NL 23 202
Hill, Jonathan Salem, US 51 145
Holland, Pamela M Belmont, US 28 1626
Lake, Andrew Westwood, US 21 41
Paterson, Alison Dedham, US 9 46

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 30, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 30, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00